Abstract

After infection of hepatitis B virus (HBV), the virus induces a variety of immune disorders in the host, leading to immune escape and, finally, the chronicity of the disease. This study investigated immune cell defects and functional impairment in patients with chronic hepatitis B (CHB). We analyzed the percentage, function, and phenotypes of various immune cell subpopulations in the peripheral blood along with the concentrations of cytokines in the plasma. We compared the results between patients with CHB and healthy individuals. It was found that in patients with CHB, the cell function was impaired and, there was increased expression of inhibitory receptors, such as NKG2A and PD-1 in both NK and T cells. The impairment of function was mainly in cytokine secretion, and the cytotoxicity was not significantly diminished. We also found that the proportion of dendritic cells (DC) decreased and regulatory B cells (Breg) increased in CHB. In addition, the Breg cells were negatively correlated with T cell cytokine and positively correlated with ALT and HBV viral load. Taken together, various disorders and functional impairments were found in the immune cells of peripheral blood in CHB patients, especially NK and T cells. These cells showed exhaustion and the increase of regulatory B cells may be one of the reasons for this phenomenon.

Highlights

  • Despite the availability of highly effective preventive vaccines and oral antiviral drugs, chronic infection with hepatitis B virus (HBV) still affects more than 240 million people worldwide and causes 620,000 deaths annually [1, 2]

  • To determine whether deficiency of antigen-presenting cells (APC) occurs in patients, we investigated the percentage of dendritic cells (DC) in patients with chronic hepatitis B (CHB) and compared it with the healthy controls

  • Our result indicates that the plasma dendritic cell (PDC) in patients with CHB was lower than those in the healthy group (p < 0.001)

Read more

Summary

Introduction

Despite the availability of highly effective preventive vaccines and oral antiviral drugs, chronic infection with hepatitis B virus (HBV) still affects more than 240 million people worldwide and causes 620,000 deaths annually [1, 2]. Most people develop an acute self-limiting disease with host immunity after infection with the virus. In patients with chronic hepatitis B (CHB), the host immune response is like a doubleedged sword. On one hand, it achieves clearance of the hepatitis B virus by destroying infected hepatocytes, and on the other hand, the immune response causes liver inflammation and aggravates liver damage, leading to liver fibrosis and hepatocellular carcinoma [6, 7]. The HBV virus can induce host immune dysfunction, causing immune imbalance and functional defects

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call